Investor500 Global is a venture capital firm based in Silicon Valley, focusing on early-stage and growth-stage technology companies worldwide. It has backed over 3,000 startups and manages $2.3 billion in assets.

HealthCap is a European venture capital firm based in Stockholm, Sweden, specializing in life sciences investments. The firm focuses on breakthrough therapies for diseases with high unmet medical needs and has financed over 130 portfolio companies since its founding in 1996.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
HealthCap is a European venture capital firm founded in 1996, based in Stockholm, Sweden. The organization specializes in investing in the life sciences sector, focusing on breakthrough therapies that address diseases with a high unmet medical need. HealthCap has raised nine funds and has financed over 130 portfolio companies, resulting in more than 35 approved pharmaceutical products and 47 initial public offerings (IPOs). The firm emphasizes emerging therapeutics that have the potential to significantly improve patient outcomes and actively collaborates with various stakeholders, including investors, the academic community, and patients, to foster a responsible and sustainable approach to investment.
HealthCap focuses on investing in companies that are developing targeted therapies for rare diseases, cancers, and genetic disorders. Their investment strategy is centered on precision medicine, aiming to develop tailored treatments that significantly improve patient outcomes. The firm actively collaborates with investors, the academic community, and patients to ensure a comprehensive approach to healthcare innovation.
HealthCap adds value to its portfolio companies by providing strategic guidance, leveraging its extensive network in the scientific and industrial communities, and facilitating executive recruitment. The firm actively engages with its portfolio companies to enhance their growth potential and market reach.
HealthCap focuses on investing in life sciences companies that develop targeted therapies for rare diseases, cancers, and genetic disorders. The firm looks for emerging therapeutics that can significantly improve patient outcomes, particularly those aligned with precision medicine.
Founders can pitch their business ideas to HealthCap by contacting Dr. Carl Kilander at carl.kilander@healthcap.eu. It is advisable to provide a detailed presentation that outlines the business model, market opportunity, and the unique value proposition of the startup.
HealthCap distinguishes itself through its deep focus on the life sciences sector and its commitment to addressing high unmet medical needs. The firm actively engages in board roles and leverages its extensive scientific and industrial networks to support portfolio companies.
While HealthCap primarily invests in Europe, it also considers opportunities globally, particularly in the Nordic region. The firm has established a strong presence in the European life sciences ecosystem.
HealthCap takes an active role in its portfolio companies, often participating in board meetings and providing strategic guidance. The firm emphasizes collaboration with its portfolio companies to enhance their growth and success.
HealthCap has raised over EUR 1.2 billion across nine funds since its founding. Specific check sizes per deal are not publicly disclosed, but the firm is known for making significant investments in its portfolio companies.
Superscout Pro
Is this page right?Reviewed · How the research works